Nalaganje...
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment and outcomes of chronic myeloid leukemia (CML). Despite their significant impact on the management of CML, there is growing evidence that TKIs may cause cardiovascular and/or metabolic complications. In this review, we present the c...
Shranjeno v:
| izdano v: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5552150/ https://ncbi.nlm.nih.gov/pubmed/28831263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S108874 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|